Abstract | PURPOSE: METHODS: RESULTS: The group receiving LT showed improvement of symptoms 7 days after beginning the study (P = 0.016), and both the LT and KT groups showed improvement from baseline on day 14 (P = 0.001 and P = 0.004, respectively). Signs improved for both the KT group (P = 0.011) and the LT group (P = 0.043) on day 7 and day 14 (P = 0.033 and P = 0.007, respectively). Mean contact lens wearing time improved on day 14 for the group treated with KT (P = 0.001). CONCLUSIONS:
|
Authors | M H Friedlaender |
Journal | The CLAO journal : official publication of the Contact Lens Association of Ophthalmologists, Inc
(CLAO J)
Vol. 22
Issue 3
Pg. 205-8
(Jul 1996)
ISSN: 0733-8902 [Print] United States |
PMID | 8828938
(Publication Type: Clinical Trial, Comparative Study, Journal Article, Randomized Controlled Trial)
|
Chemical References |
- Anti-Inflammatory Agents, Non-Steroidal
- Histamine H1 Antagonists
- Nitriles
- Ophthalmic Solutions
- Tromethamine
- Ketorolac Tromethamine
- lodoxamide tromethamine
- Tolmetin
- Oxamic Acid
|
Topics |
- Administration, Topical
- Anti-Inflammatory Agents, Non-Steroidal
(administration & dosage, therapeutic use)
- Conjunctiva
(drug effects, pathology)
- Conjunctivitis, Allergic
(drug therapy, etiology)
- Contact Lenses
(adverse effects)
- Double-Blind Method
- Follow-Up Studies
- Histamine H1 Antagonists
(administration & dosage, therapeutic use)
- Humans
- Ketorolac Tromethamine
- Models, Biological
- Nitriles
- Ophthalmic Solutions
- Oxamic Acid
(administration & dosage, analogs & derivatives, therapeutic use)
- Tolmetin
(administration & dosage, analogs & derivatives, therapeutic use)
- Tromethamine
(administration & dosage, analogs & derivatives, therapeutic use)
|